Showing 511-520 of 2269 results for "".
Innovations in Parkinson's Disease: Deep Brain Stimulation and Magnetic Resonance-guided Focused Ultrasound
https://practicalneurology.com/diseases-diagnoses/movement-disorders/innovations-in-parkinsons-disease-deep-brain-stimulation-and-magnetic-resonance-guided-focused-ultrasound/30500/Rapid progress in deep brain stimulation and focused ultrasound offer a glimpse of the future of treatment for Parkinson's disease.Monoclonal Antibody Therapy in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/monoclonal-antibody-therapy-in-multiple-sclerosi/30209/Finding the forest among the trees with an update on the safety, efficacy, and mechanisms of monoclonal antibodies.Dementia Insights
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights/30798/Multiple White Matter Hyperintense LesionsDeep Brain Stimulation in Parkinson's Disease: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/movement-disorders/deep-brain-stimulation-in-parkinsons-disease-past-present-and-future/30474/Though it has been underutilized over the past two decades, deep brain stimulation is an effective intervention for many individuals with Parkinson's disease.An Alternative Pathway to the ABPN Maintenance of Certification
https://practicalneurology.com/columns/practice-management/an-alternative-pathway-to-the-abpn-maintenance-of-certification/30494/The Fragile X-Associated Tremor/Ataxia Syndrome
https://practicalneurology.com/diseases-diagnoses/movement-disorders/PN0809_08-php/30899/Relatively recently described, FXTAS is a progressive genetic disorder for which there is no cure, but symptomatic therapy is indicated.Seizures and Epilepsy in the Elderly
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/seizures-and-epilepsy-in-the-elderly/30259/A focus on multidisciplinary care.Hyperkinetic Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hyperkinetic-movement-disorders/30248/New treatments were approved in 2017 for tardive dyskinesia, Parkinson's dyskinesia, and Huntington's chorea.Calcitonin Gene-Related Peptide Monoclonal Antibodies
https://practicalneurology.com/diseases-diagnoses/headache-pain/calcitonin-gene-related-peptide-monoclonal-antibodies/30275/A new treatment for managing migraine in the clinic is on the horizon.Why Neuroimaging Plays a Critical Role in Shaping the Future of Neurology
https://practicalneurology.com/diseases-diagnoses/imaging-testing/viewpoints-why-neuroimaging-plays-a-critical-role-in-shaping-the-future-of-neurology/30403/An integral part of clinical neurology and neurosciences, neuroimaging training must be better harnessed and incorporated into the educational spectrum of the specialty.